Sales decline 0.06% to Rs 94.82 crore
Net Loss of Sterling Biotech reported to Rs 109.50 crore in the quarter ended June 2017 as against net loss of Rs 87.54 crore during the previous quarter ended June 2016. Sales declined 0.06% to Rs 94.82 crore in the quarter ended June 2017 as against Rs 94.88 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales94.8294.88 0 OPM %0.5311.60 -PBDT-100.77-67.63 -49 PBT-167.45-133.87 -25 NP-109.50-87.54 -25Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
